0001415889-23-011525.txt : 20230727 0001415889-23-011525.hdr.sgml : 20230727 20230727163043 ACCESSION NUMBER: 0001415889-23-011525 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230725 FILED AS OF DATE: 20230727 DATE AS OF CHANGE: 20230727 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Paolini John F. CENTRAL INDEX KEY: 0001741533 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38492 FILM NUMBER: 231118937 MAIL ADDRESS: STREET 1: C/O KINIKSA PHARMACEUTICALS, LTD. STREET 2: CLARENDON HOUSE, 2 CHURCH STREET CITY: HAMILTON STATE: D0 ZIP: HM11 FORMER NAME: FORMER CONFORMED NAME: Paolini John DATE OF NAME CHANGE: 20180522 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kiniksa Pharmaceuticals, Ltd. CENTRAL INDEX KEY: 0001730430 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: D0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CLARENDON HOUSE STREET 2: 2 CHURCH STREET CITY: HAMILTON STATE: D0 ZIP: HM11 BUSINESS PHONE: 7814399100 MAIL ADDRESS: STREET 1: CLARENDON HOUSE STREET 2: 2 CHURCH STREET CITY: HAMILTON STATE: D0 ZIP: HM11 4 1 form4-07272023_080730.xml X0508 4 2023-07-25 0001730430 Kiniksa Pharmaceuticals, Ltd. KNSA 0001741533 Paolini John F. C/O KINIKSA PHARMACEUTICALS, LTD. CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM 11 BERMUDA false true false false CHIEF MEDICAL OFFICER 0 Class A Common Share 2023-07-25 4 M 0 29000 1.86 A 70910 D Class A Common Share 2023-07-25 4 S 0 5200 18.01 D 65710 D Class A Common Share 2023-07-25 4 S 0 16168 19.25 D 49542 D Class A Common Share 2023-07-25 4 S 0 7632 19.69 D 41910 D Share Option 1.86 2023-07-25 4 M 0 29000 0 D 2026-09-13 Class A Common Share 29000 140217 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan executed by the reporting person on August 16, 2022. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $17.50 to $18.49. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $18.50 to $19.49. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $19.50 to $19.94. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. The option is fully vested and exercisable. /s/ Madelyn Zeylikman, Attorney-in-Fact 2023-07-27